en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

LLY

802.55

-2.25%↓

UNH

569.62

+1.64%↑

NVO

126.83

-0.63%↓

JNJ

160.55

+0.48%↑

MRK

125.13

-0.6%↓

Home・Stock List・Beam Therapeutics Inc
Search

Beam Therapeutics Inc

Closed

Sector Healthcare

29.85 -1.62

Buy

Price update 24 Jul 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

29.44

Max

30.9

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+50.26 upside

Dividends

By Dow Jones

Next Earnings

6 Aug 2024

News Sentiment

By Acuity

25%

75%

55 / 369 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

25.88 / N/A Support & Resistance

Beam Therapeutics Inc Chart

Related News

31 Oct 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

DJ

Read

24 Nov 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

DJ

Read

31 Oct 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

DJ

Read

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

50.26% upside

12 Months Forecast

Average 45.56 USD  50.26%

High 80 USD

Low 27 USD

Based on 11 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

6

Buy

5

Hold

0

Sell

Based on 11 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

25.88 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Neutral Evidence

The bullish and bearish events are balanced.

Sentiment

By Acuity

55 / 369 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Other stocks from the sector

LLY

Eli Lilly and Co.

802.55

↓-2.25%

UNH

UnitedHealth Group Inc

569.62

↑ +1.64%

NVO

Novo Nordisk A-S

126.83

↓-0.63%

JNJ

Johnson and Johnson

160.55

↑ +0.48%

MRK

Merck & Co Inc.

125.13

↓-0.6%